博拓生物
(688767)
| 流通市值：61.14亿 | | | 总市值：61.14亿 |
| 流通股本：1.49亿 | | | 总股本：1.49亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,250,654,934.49 | 1,389,606,250.68 | 1,475,644,776.95 | 1,523,661,649.38 |
| 交易性金融资产 | 13,925,595.7 | 13,925,501.75 | 13,759,360.65 | - |
| 应收票据及应收账款 | 96,069,046.64 | 86,957,331.69 | 89,374,325.97 | 84,797,357.74 |
| 应收账款 | 96,069,046.64 | 86,957,331.69 | 89,374,325.97 | 84,797,357.74 |
| 预付款项 | 4,212,459.45 | 6,187,398.26 | 4,222,035.55 | 6,558,826.22 |
| 其他应收款合计 | 1,750,842.79 | 2,176,773.34 | 3,438,063.37 | 1,533,918.83 |
| 存货 | 69,727,967.06 | 71,730,731.83 | 69,680,329.99 | 71,816,959.16 |
| 其他流动资产 | 9,720,913.89 | 9,747,740.31 | 5,366,312.04 | 14,772,391.52 |
| 流动资产合计 | 1,446,061,760.02 | 1,580,331,727.86 | 1,661,485,204.52 | 1,703,141,102.85 |
| 非流动资产: | | | | |
| 长期股权投资 | 67,874,107.33 | 42,534,280.69 | 13,409,948.17 | 10,102,743.34 |
| 其他权益工具投资 | - | - | - | 18,000,000 |
| 其他非流动金融资产 | 18,000,000 | 18,000,000 | 18,000,000 | - |
| 投资性房地产 | 748,963.5 | 4,059,717.02 | 4,116,457.45 | 4,173,197.9 |
| 固定资产 | 307,862,910.35 | 306,352,460.48 | 311,290,190.52 | 313,315,111.39 |
| 在建工程 | 257,666,394.84 | 228,384,951.71 | 229,575,945.56 | 132,620,159.3 |
| 无形资产 | 267,320,980.32 | 267,890,216.31 | 269,309,345.03 | 271,039,788.41 |
| 递延所得税资产 | 16,733,139.96 | 13,992,696.04 | 10,100,309.91 | 10,719,143.11 |
| 其他非流动资产 | 23,208,979.42 | 24,450,911.68 | 22,136,619.85 | 11,901,500 |
| 非流动资产合计 | 959,415,475.72 | 905,665,233.93 | 877,938,816.49 | 771,871,643.45 |
| 资产总计 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 | 2,475,012,746.3 |
| 流动负债: | | | | |
| 短期借款 | 604,963.75 | 435,359.45 | 488,318.85 | 190,643.98 |
| 应付票据及应付账款 | 102,114,093.97 | 65,474,288.73 | 98,670,077.54 | 53,525,697.02 |
| 应付账款 | 102,114,093.97 | 65,474,288.73 | 98,670,077.54 | 53,525,697.02 |
| 合同负债 | 14,179,833.27 | 11,737,012.49 | 15,156,568.57 | 14,301,488.73 |
| 应付职工薪酬 | 9,652,692.76 | 6,599,922.27 | 15,553,217.97 | 8,768,376.3 |
| 应交税费 | 2,355,475.01 | 1,782,118.42 | 3,726,559.37 | 3,324,784.67 |
| 其他应付款合计 | 22,941,412.99 | 25,689,023.62 | 24,274,454.35 | 44,321,328.04 |
| 应付股利 | - | - | 53,208,333.5 | - |
| 一年内到期的非流动负债 | 69,809.12 | - | - | - |
| 其他流动负债 | 191,433.04 | 264,390.03 | 107,300.57 | 271,129.89 |
| 流动负债合计 | 152,109,713.91 | 111,982,115.01 | 157,976,497.22 | 124,703,448.63 |
| 非流动负债: | | | | |
| 长期借款 | 99,502,812.02 | - | - | - |
| 递延收益 | 9,328,964.16 | 9,751,160.28 | 10,191,636.08 | 10,050,205.26 |
| 非流动负债合计 | 108,831,776.18 | 9,751,160.28 | 10,191,636.08 | 10,050,205.26 |
| 负债合计 | 260,941,490.09 | 121,733,275.29 | 168,168,133.3 | 134,753,653.89 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 149,333,334 | 149,333,334 | 149,333,334 | 149,333,334 |
| 资本公积 | 752,574,739.01 | 752,275,739.1 | 751,677,739.02 | 756,583,962.71 |
| 减:库存股 | 127,453,912.02 | 18,070,100 | 18,070,100 | 28,018,500 |
| 其他综合收益 | 1,987,364.57 | 1,536,089.83 | 1,235,499.94 | 2,020,263.53 |
| 盈余公积 | 59,350,074.28 | 59,350,074.28 | 59,350,074.28 | 53,333,333.5 |
| 未分配利润 | 1,305,177,369.32 | 1,416,055,392.76 | 1,426,263,267.53 | 1,405,289,834.59 |
| 归属于母公司股东权益合计 | 2,140,968,969.16 | 2,360,480,529.97 | 2,369,789,814.77 | 2,338,542,228.33 |
| 少数股东权益 | 3,566,776.49 | 3,783,156.53 | 1,466,072.94 | 1,716,864.08 |
| 股东权益合计 | 2,144,535,745.65 | 2,364,263,686.5 | 2,371,255,887.71 | 2,340,259,092.41 |
| 负债和股东权益合计 | 2,405,477,235.74 | 2,485,996,961.79 | 2,539,424,021.01 | 2,475,012,746.3 |
| 公告日期 | 2026-08-29 | 2026-04-25 | 2026-04-25 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |